Identifying genetic differences between bipolar disorder and major depression through multiple genome-wide...

Area of Science:

• Psychiatric Genetics
• Genomics
• Computational Biology

Background:

• Accurate diagnosis of bipolar disorder (BPD) is challenging, with a significant delay from symptom onset to diagnosis.
• Distinguishing BPD from unipolar major depressive disorder (MDD) is difficult, especially when BPD presents with a depressive episode first.

Purpose of the Study:

• To identify genetic factors differentiating BPD and MDD using genome-wide association studies (GWAS).
• To develop polygenic risk score (PRS) predictors for early differential diagnosis of BPD and MDD.

Main Methods:

• Genome-wide association analyses (GWAS) and polygenic risk score (PRS) analyses were performed on a large cohort.
• The study utilized individual genotypes from case-control cohorts of BPD and MDD from the Psychiatric Genomics Consortium.
• A combined cohort of 51,149 individuals (15,532 BPD, 12,920 MDD, 22,697 controls) was analyzed after rigorous quality control.

Main Results:

• Significant chip heritability was found, indicating a genetic component for BPD and MDD.
• Polygenic risk scores (PRS) demonstrated the ability to distinguish BPD from MDD, including BPD with depressive onset (BPD-D).
• PRS findings were successfully replicated in an independent Danish cohort (iPSYCH 2015).

Conclusions:

• Major depressive disorder (MDD) and bipolar disorder (BPD), including BPD with depressive onset (BPD-D), are genetically distinct.
• Findings suggest a continuum of genetic risk across controls, MDD, and BPD patients.
• Future research with larger sample sizes is needed to refine genetic predictors for differential diagnosis.